Amarillo Biosciences Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.04 |
Market Cap |
$12.98 M |
Shares Outstanding |
39.66 M |
Public Float |
24.17 M |
Address |
4134 Business Park Drive Amarillo Texas 79110 United States |
Employees | - |
Website | http://www.amarbio.com |
Updated | 07/08/2019 |
Amarillo Biosciences, Inc. engages in developing biologics for the treatment of human and animal diseases. It focuses on research aimed at the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon alpha that is administered in a proprietary low dose oral form. The company was founded by Joseph M. |